Literature DB >> 11581238

Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media.

P C Fuchs1, A L Barry, S D Brown.   

Abstract

One hundred and ninety-five Gram-positive bacteria representing 17 species were tested for susceptibility to daptomycin by broth microdilution and Etest methods. The geometric mean daptomycin MIC was 0.46 mg/L by broth microdilution tests and 0.73 mg/L by Etest. The concentration of calcium in 12 different batches of agar varied from 4 to 36 mg/L. Daptomycin Etest MICs varied inversely with the calcium concentration. Etest daptomycin MICs for quality control strains were within proposed quality control range on media with >20 mg/L of calcium. Monitoring the calcium levels of agar media by testing appropriate quality control strains is important for daptomycin Etests.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581238     DOI: 10.1093/jac/48.4.557

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Authors:  Jose M Munita; Diana Panesso; Lorena Diaz; Truc T Tran; Jinnethe Reyes; Audrey Wanger; Barbara E Murray; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.

Authors:  Laura A Jevitt; Grace M Thorne; Maria M Traczewski; Ronald N Jones; John E McGowan; Fred C Tenover; Steven D Brown
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  Evaluating the Rapid Emergence of Daptomycin Resistance in Corynebacterium: a Multicenter Study.

Authors:  Kaitlin F Mitchell; Erin McElvania; Meghan A Wallace; Lauren E Droske; Amy E Robertson; Lars F Westblade; C A Burnham
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

Review 4.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Activity of daptomycin against recent North American isolates of Streptococcus pneumoniae.

Authors:  M I Restrepo; J A Velez; M L McElmeel; C G Whitney; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods.

Authors:  James H Jorgensen; Sharon A Crawford; Cynthia C Kelly; Jan E Patterson
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

7.  β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus.

Authors:  Andrew D Berti; George Sakoulas; Victor Nizet; Ryan Tewhey; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

8.  Systematic evaluation of commercial susceptibility testing methods for determining the in vitro activity of daptomycin versus Staphylococcus aureus and Enterococci.

Authors:  Thomas J Kirn; Elizabeth Onyeaso; Madiha Syed; Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

Review 9.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Variability of Beta-Lactam Broth Microdilution for Pseudomonas aeruginosa.

Authors:  A A Bhalodi; N Oppermann; S A Campeau; R M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.